J. Edwards

J.
Michael Edwards is currently Chief Financial Officer at bioAffinity Technologies, Inc. since 2024.
Former positions include Regional Director-Finance & Accounting at Fieldstone Utah Investors LLC from 2006 to 2007; Assistant Controller at ILEX Oncology, Inc. from 2000 to 2001; Principal at Progress Energy, Inc.; Chief Financial Officer at Aviation Upgrade Technologies, Inc. in 2008; Controller at BioNumerik Pharmaceuticals, Inc. from 2001 to 2006; Auditor at PricewaterhouseCoopers LLP from 1992 to 1995; Executive Vice President at TurboGenix, Inc.; Chief Accounting Officer at U.S.
Global Investors, Inc. from 1997 to 1999; Principal at Planergy, Inc.; Chief Financial Officer at OncoVista, Inc. in 2008; Chief Financial Officer at OncoVista Innovative Therapies, Inc. from 2008 to 2011; Chief Financial Officer at bioAffinity Technologies, Inc.; and Chief Financial Officer at CytoBioscience, Inc. Education includes graduate studies at The University of Texas at Austin, an MBA from McCombs School of Business, and undergraduate studies at the University of Texas at San Antonio.